Micafungina Sala

Micafungin, the active ingredient in Micafungina Sala, is an echinocandin presented as an injection solution for intravenous use. It treats invasive candidiasis, esophageal candidiasis and is used for prophylaxis of Candida infections in hematopoietic stem cell transplant recipients.

GNH USA supplies Micafungina Sala as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Micafungin is an echinocandin antifungal indicated for several Candida infections.

- Invasive candidiasis: effective treatment of bloodstream and deep‑seated Candida infections. - Esophageal candidiasis: resolves mucosal infection of the esophagus caused by Candida species. - Prophylaxis in hematopoietic stem cell transplant recipients: prevents Candida infection during the high‑risk post‑transplant period.

Micafungin may cause a range of adverse reactions, most of which are manageable.

Common Side Effects: - Fever: mild to moderate temperature elevation. - Nausea: occasional upset stomach. - Vomiting: occasional emesis. - Headache: transient cranial discomfort. - Infusion‑related reactions: flushing, chills, or mild hypotension. - Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects: - Hepatotoxicity: significant liver injury requiring monitoring. - Severe hypersensitivity: anaphylaxis or angioedema. - Renal impairment: acute kidney injury in susceptible patients. - Severe neutropenia: marked reduction in neutrophil count. - Stevens‑Johnson syndrome: rare severe skin reaction. - Cardiac arrhythmia: uncommon rhythm disturbances.

When using Micafungina Sala, clinicians should observe several safety measures.

- Renal function: monitor serum creatinine and urine output. - Hepatic function: assess baseline liver enzymes and repeat as needed. - Concomitant hepatotoxic drugs: avoid or use with caution. - Pregnancy: risk unknown; prescribe only if benefits outweigh potential risks. - Pediatric use: limited data; consider specialist advice. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with other medicines; awareness of interaction severity helps guide therapy.

Major Interactions (Avoid): - Cyclosporine: may increase micafungin plasma concentrations. - Other echinocandins: concurrent use offers no added benefit and raises toxicity risk. - Strong hepatotoxins: combined use can exacerbate liver injury.

Moderate Interactions (Monitor Closely): - Rifampin: may reduce micafungin exposure. - Azole antifungals (e.g., fluconazole): potential additive hepatotoxicity. - Immunosuppressants (e.g., tacrolimus): monitor drug levels for possible alteration. - Statins: observe for increased liver enzyme changes.